CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion | +492,475 | 2,418,548 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion | +20,519 | 100,772 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion · Series B Convertible Preferred Stock | −1,913,910 | 0 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion · Series B Convertible Preferred Stock | −79,746 | 0 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion · Series C Convertible Preferred Stock | −492,475 | 0 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion · Series C Convertible Preferred Stock | −20,519 | 0 | ||
| 2019-10-07 | Magni Guido Director | Purchase | +6,500 | $15.00 | $98K | 6,500 |
| 2019-10-07 | HENNEMAN JOHN B III Director | Purchase | +5,000 | $15.00 | $75K | 5,000 |
| 2019-10-07 | HENNEMAN JOHN B III Director | Grant or award · Stock Option (right to Buy) | +18,407 | 18,407 | ||
| 2019-10-07 | Korbel Gregory Alan VP of Business Dev't | Purchase | +500 | $15.00 | $8K | 500 |
| 2019-10-07 | Korbel Gregory Alan VP of Business Dev't | Grant or award · Stock Option (right to Buy) | +64,322 | 64,322 | ||
| 2019-10-07 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +77,630 | 77,630 | ||
| 2019-10-07 | Attar Eyal C. SVP, Chief Medical Officer | Purchase | +200 | $15.00 | $3K | 200 |
| 2019-10-07 | Attar Eyal C. SVP, Chief Medical Officer | Purchase | +200 | $15.00 | $3K | 200 |
| 2019-10-07 | Attar Eyal C. SVP, Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +77,630 | 77,630 | ||
| 2019-10-07 | Coiante Scott M SVP, Chief Financial Officer | Purchase | +2,500 | $15.00 | $38K | 2,500 |
| 2019-10-07 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +150,824 | 150,824 | ||
| 2019-10-07 | SCHADE CHRISTIAN S President & CEO | Purchase | +1,000 | $15.00 | $15K | 1,000 |
| 2019-10-07 | SCHADE CHRISTIAN S President & CEO | Purchase | +1,000 | $15.00 | $15K | 1,000 |
| 2019-10-07 | SCHADE CHRISTIAN S President & CEO | Purchase | +1,000 | $15.00 | $15K | 1,000 |
Page 16 of 17 · 334 trades